[ad_1] The FDA today issued an Emergency Use Permit (EUA) for baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory-confirmed coronaviruses in hospitalized adults and pediatric patients two years of age or longer than required. Supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO), according to …
Read More »FDA approves emergency use of baritcinib with remdesivir for the treatment of Corona
